View Older Stories View More Recent Stories

Nov 8, 2024 07:06AM Amgen (AMGN): Tezspire Met Both Co-primary Endpoints In Phase 3 Trial For Chronic Rhinosinusitis With Nasal Polyps
Oct 30, 2024 04:02PM Amgen (AMGN) Tops Q3 EPS by 47c; offers guidance
Oct 30, 2024 10:57AM Amgen (AMGN) November 1 weekly option implied volatility into quarter results
Oct 29, 2024 11:21AM Amgen (AMGN) option IV at high end of range into quarter results
Oct 25, 2024 04:01PM Amgen (AMGN) Declares $2.25 Quarterly Dividend; 2.8% Yield
Oct 22, 2024 03:26PM Amgen (AMGN) Launches Pavblu As Rival To Regeneron's (REGN) Eylea - Bloomberg
Oct 21, 2024 08:24AM Amgen (AMGN) PT Raised to $383 at TD Cowen
Oct 16, 2024 06:02AM Goldman Sachs Reiterates Conviction Buy Rating on Amgen (AMGN)
Oct 15, 2024 02:20PM TD Cowen Reiterates Buy Rating on Amgen (AMGN)
Oct 15, 2024 08:01AM Amgen (AMGN) presents positive top-line results from the Phase 3 MINT trial
Oct 14, 2024 06:05AM Truist Securities Downgrades Amgen (AMGN) to Hold
Sep 25, 2024 03:12PM Amgen (AMGN) October 350 and 360 calls active as share price down 5.3%
Sep 25, 2024 08:22AM Goldman Sachs Reiterates Buy Rating on Immunovant (IMVT)
Sep 25, 2024 07:35AM TD Cowen Reiterates Buy Rating on Amgen (AMGN)
Sep 25, 2024 07:23AM BMO Capital Reiterates Outperform Rating on Amgen (AMGN)
Sep 25, 2024 07:14AM Piper Sandler Reiterates Overweight Rating on Amgen (AMGN)
Sep 25, 2024 06:49AM Baird Reiterates Underperform Rating on Amgen (AMGN)
Sep 25, 2024 05:43AM Truist Securities Reiterates Buy Rating on Amgen (AMGN)
Sep 24, 2024 04:00PM Amgen (AMGN) Tepezza Receives Approval In Japan For The Treatment Of Active Thyroid Eye Disease
Sep 23, 2024 04:01PM Amgen (AMGN) To Host Conference Call To Discuss New Topline Data In Inflammation And Rare Disease
Sep 17, 2024 06:03AM Oppenheimer Reiterates Outperform Rating on Amgen (AMGN)
Aug 20, 2024 09:01AM Amgen (AMGN): Otezla Now Available In The U.S. For Moderate To Severe Pediatric Plaque Psoriasis
Aug 15, 2024 09:20AM TD Cowen Reiterates Buy Rating on Amgen (AMGN)
Aug 7, 2024 12:28PM Midday movers: Super Micro Computer, Airbnb and Lyft fall; Shopify rises
Aug 7, 2024 10:09AM Amgen (AMGN) PT Raised to $381 at TD Cowen
Aug 7, 2024 06:26AM Amgen (AMGN) PT Raised to $362 at RBC Capital
Aug 7, 2024 05:03AM Stocks expected to have increasing option volume: AMGN ABNB FTNT SMCI RIVN TOST RDDT WYNN VFC CRUS IAC TRIP
Aug 7, 2024 04:34AM Wells Fargo Downgrades Amgen (AMGN) to Equal Weight
Aug 6, 2024 04:03PM Amgen (AMGN) Misses Q2 EPS by 1c; updates guidance
Aug 2, 2024 04:00PM Amgen (AMGN) Declares $2.25 Quarterly Dividend; 2.7% Yield
Jul 30, 2024 07:17AM RBC's biotech survey shows investors more bearish vs. last time
Jul 21, 2024 06:00AM 10 policies if Trump wins and stock implications: Jefferies
Jul 17, 2024 06:32AM Deutsche Bank Reiterates Hold Rating on Amgen (AMGN)
Jul 12, 2024 11:14AM Amgen (AMGN) PT Raised to $337 at UBS
Jul 9, 2024 07:00PM 2Q24 U.S. biotech earnings preview
Jul 8, 2024 12:21PM Jefferies Reiterates Buy Rating on Amgen (AMGN)
Jul 3, 2024 05:30AM Amgen (AMGN) option implied volatility flat
Jun 27, 2024 01:08PM Amgen (AMGN) PT Raised to $340 at Argus
Jun 14, 2024 06:15AM Amgen (AMGN) PT Raised to $332 at RBC Capital
View More Recent Stories View Older Stories